Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4017)
All Articles published online
|
Oct 28, 2008 (publication date) through Nov 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ishikawa T. Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients. World J Gastroenterol 2008; 14(40): 6140-6144 [PMID: 18985803 DOI: 10.3748/wjg.14.6140] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i40/6140.htm |
| Number | Citing Articles |
| 1 |
Ahmed Lasfar, Andrew de la Torre, Walid Abushahba, Karine A. Cohen-Solal, Ismael Castaneda, Yao Yuan, Kenneth Reuhl, Andrew Zloza, Elizabeth Raveche, Debra L. Laskin, Sergei V. Kotenko. Concerted action of IFN-α and IFN-λ induces local NK cell immunity and halts cancer growth. Oncotarget 2016; 7(31): 49259 doi: 10.18632/oncotarget.10272
|
| 2 |
Asmaa I Gomaa, Imam Waked. Recent advances in multidisciplinary management of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(4): 673-687 doi: 10.4254/wjh.v7.i4.673
|
| 3 |
Kun He, Hua Chen, Tianshou Cao, Jiantao Lin. Elucidation of the Mechanisms and Molecular Targets of Shuanglian Decoction for the Treatment of Hepatocellular Carcinoma Based on Network Pharmacology. ACS Omega 2021; 6(1): 917 doi: 10.1021/acsomega.0c05550
|
| 4 |
Jun-ichi Okano, Yuki Fujise, Ryo Abe, Ryu Imamoto, Yoshikazu Murawaki. Chemoprevention against hepatocellular carcinoma. Clinical Journal of Gastroenterology 2011; 4(4): 185 doi: 10.1007/s12328-011-0227-8
|
| 5 |
Manzoor Ahmad Mir, Shariqa Aisha, Shazia Sofi. Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies. 2022; : 1 doi: 10.1016/B978-0-443-18696-7.00010-5
|
| 6 |
Ying Hu, Chuanhua Yu, Banghua Chen, Lei Wang. Implication of reported viral hepatitis incidence rate change in Hubei Province, China, between 2004–2010. Journal of Huazhong University of Science and Technology [Medical Sciences] 2012; 32(3): 428 doi: 10.1007/s11596-012-0074-y
|
| 7 |
Chia-Chi Wang, Jia-Horng Kao. How have the recent advances in antiviral therapy impacted the management of virus-related hepatocellular carcinoma?. Expert Opinion on Pharmacotherapy 2016; 17(7): 911 doi: 10.1517/14656566.2016.1149165
|
| 8 |
Joseph Ahn, Steven L. Flamm. Hepatitis C and hepatocellular carcinoma: New developments in natural history and treatment. Current Hepatitis Reports 2009; 8(2): 59 doi: 10.1007/s11901-009-0009-7
|
| 9 |
G. Cenderello, E. Pontali, G. Cassola, A. Torresin. Could anti-HCV treatment prevent recurrence of hepatocellular carcinoma in HIV-infected patients? Two case reports. Infection 2013; 41(1): 199 doi: 10.1007/s15010-012-0353-3
|
| 10 |
|
| 11 |
Amanda Vestito, Elton Dajti, Fabio Cortellini, Marco Montagnani, Franco Bazzoli, Rocco Maurizio Zagari. Can Liver Ultrasound Elastography Predict the Risk of Hepatocellular Carcinoma Recurrence After Radiofrequency Ablation? A Systematic Review and Meta-Analysis. Ultraschall in der Medizin - European Journal of Ultrasound 2023; 44(03): e139 doi: 10.1055/a-1657-8825
|
| 12 |
Gabriella Lengyel, János Fehér†. Combined interferon, ribavirin treatment and the occurrence of hepatocellular carcinoma. Orvosi Hetilap 2010; 151(29): 1177 doi: 10.1556/oh.2010.28925
|
| 13 |
Ahmed Lasfar, Helen Gogas, Andrew Zloza, Howard L Kaufman, John M Kirkwood. IFN-λ Cancer Immunotherapy: New Kid on the Block. Immunotherapy 2016; 8(8): 877 doi: 10.2217/imt-2015-0021
|
| 14 |
|
| 15 |
Jung-Hwan Yu, Ja Kyung Kim, Kwan Sik Lee, Jung Il Lee. Antiviral Therapy in Patients With Chronic Hepatitis C-related Hepatocellular Carcinoma Responding to Palliative Treatment. Journal of Clinical Gastroenterology 2018; 52(6): 557 doi: 10.1097/MCG.0000000000000923
|
| 16 |
Tatyana O Kabilova, Larisa V Kovtonyuk, Evgeniy V Zonov, Elena I Ryabchikova, Nelly A Popova, Valeriy P Nikolin, Vasiliy I Kaledin, Marina A Zenkova, Valentin V Vlassov, Elena L Chernolovskaya. Immunotherapy of hepatocellular carcinoma with small double-stranded RNA. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-338
|
| 17 |
Hie‐Won Hann, Robert Coben, Daniel Brown, Laurence Needleman, Ernest Rosato, Albert Min, Richard S. Hann, Kyong Bin Park, Stephen Dunn, Anthony J. DiMarino. A long‐term study of the effects of antiviral therapy on survival of patients with HBV‐associated hepatocellular carcinoma (HCC) following local tumor ablation. Cancer Medicine 2014; 3(2): 390 doi: 10.1002/cam4.197
|
| 18 |
Hardeep Kaur, Soma Mondal Ghorai. Immunomodulators and Human Health. 2022; : 371 doi: 10.1007/978-981-16-6379-6_13
|
| 19 |
Toru Ishikawa. Future perspectives on the treatment of hepatocellular carcinoma with cisplatin. World Journal of Hepatology 2009; 1(1): 8-16 doi: 10.4254/wjh.v1.i1.8
|
| 20 |
Roniel Cabrera, Renumathy Dhanasekaran, James Caridi, Virgina Clark, Giuseppe Morelli, Consuelo Soldevila-Pico, Joseph Magglioca, David Nelson, Roberto Jose Firpi. Impact of Transarterial Therapy in Hepatitis C-Related Hepatocellular Carcinoma on Long-term Outcomes After Liver Transplantation. American Journal of Clinical Oncology 2012; 35(4): 345 doi: 10.1097/COC.0b013e31821631f6
|